<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37243223</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1137</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15051137</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC) is a common disease characterized by cardiac inflammation. AC-73, an inhibitor of CD147, disrupts the dimerization of CD147, which participates in the regulation of inflammation. To explore whether AC-73 could alleviate cardiac inflammation induced by CVB3, mice were injected intraperitoneally with AC-73 on the fourth day post-infection (dpi) and sacrificed on the seventh dpi. Pathological changes in the myocardium, T cell activation or differentiation, and expression of cytokines were analyzed using H&amp;E staining, flow cytometry, fluorescence staining and multiplex immunoassay. The results showed that AC-73 alleviated cardiac pathological injury and downregulated the percentage of CD45<sup>+</sup>CD3<sup>+</sup> T cells in the CVB3-infected mice. The administration of AC-73 reduced the percentage of activated CD4<sup>+</sup> and CD8<sup>+</sup> T cells (CD69<sup>+</sup> and/or CD38<sup>+</sup>) in the spleen, while the percentage of CD4<sup>+</sup> T cell subsets in the spleen was not changed in the CVB3-infected mice. In addition, the infiltration of activated T cells (CD69<sup>+</sup>) and macrophages (F4/80<sup>+</sup>) in the myocardium also decreased after the AC-73 treatment. The results also showed that AC-73 inhibited the release of many cytokines and chemokines in the plasma of the CVB3-infected mice. In conclusion, AC-73 mitigated CVB3-induced myocarditis by inhibiting the activation of T cells and the recruitment of immune cells to the heart. Thus, CD147 may be a therapeutic target for virus-induced cardiac inflammation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruifang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zong</LastName><ForeName>Kexin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Qinqin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Haijun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Hailan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Immunology, Capital Institute of Pediatrics, YaBao Rd., Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0803-4403</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Rd., Beijing 102206, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000709216">AC-73</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD147</Keyword><Keyword MajorTopicYN="N">T cell activation</Keyword><Keyword MajorTopicYN="N">Th cell subsets</Keyword><Keyword MajorTopicYN="N">anti-inflammation</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37243223</ArticleId><ArticleId IdType="pmc">PMC10221111</ArticleId><ArticleId IdType="doi">10.3390/v15051137</ArticleId><ArticleId IdType="pii">v15051137</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caforio A.L., Pankuweit S., Arbustini E., Basso C., Gimeno-Blanes J., Felix S.B., Fu M., Heliö T., Heymans S., Jahns R., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013;34:2636–2648. doi: 10.1093/eurheartj/eht210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L.T., Jr. Myocarditis. N. Engl. J. Med. 2009;360:1526–1538. doi: 10.1056/NEJMra0800028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0800028</ArticleId><ArticleId IdType="pmc">PMC5814110</ArticleId><ArticleId IdType="pubmed">19357408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S., Liu P.P., Cooper L.T., Jr. Myocarditis. Lancet. 2012;379:738–747. doi: 10.1016/S0140-6736(11)60648-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Belke D.D., Garnett L., Martens K., Abdelfatah N., Rodriguez M., Diao C., Chen Y.X., Gordon P.M., Nygren A., et al. Transgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling. PLoS ONE. 2017;12:e0174019. doi: 10.1371/journal.pone.0174019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174019</ArticleId><ArticleId IdType="pmc">PMC5365111</ArticleId><ArticleId IdType="pubmed">28339476</ArticleId></ArticleIdList></Reference><Reference><Citation>Trachtenberg B.H., Hare J.M. Inflammatory Cardiomyopathic Syndromes. Circ. Res. 2017;121:803–818. doi: 10.1161/CIRCRESAHA.117.310221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310221</ArticleId><ArticleId IdType="pubmed">28912184</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008;3:127–155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Carai P., Florit Gonzalez L., Van Bruggen S., Spalart V., De Giorgio D., Geuens N., Martinod K., Jones E.A.V., Heymans S. Neutrophil Inhibition Improves Acute Inflammation in a Murine Model of Viral Myocarditis. Cardiovasc. Res. 2022;118:3331–3345. doi: 10.1093/cvr/cvac052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac052</ArticleId><ArticleId IdType="pmc">PMC9847559</ArticleId><ArticleId IdType="pubmed">35426438</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis—Diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670–680. doi: 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Fu Z. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy. J. Immunol. Res. 2018;2018:5301548. doi: 10.1155/2018/5301548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5301548</ArticleId><ArticleId IdType="pmc">PMC5964556</ArticleId><ArticleId IdType="pubmed">29854842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Yang F., Shi S., Liu X., Qin F., Wei X., Huang Y., Liang W., Miao L. The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice. Mediat. Inflamm. 2021;2021:5551578. doi: 10.1155/2021/5551578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5551578</ArticleId><ArticleId IdType="pmc">PMC8139334</ArticleId><ArticleId IdType="pubmed">34093086</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal R., Marinelli M.A., Alcorn J.F. Immune Mechanisms in Cardiovascular Diseases Associated with Viral Infection. Front. Immunol. 2020;11:570681. doi: 10.3389/fimmu.2020.570681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.570681</ArticleId><ArticleId IdType="pmc">PMC7642610</ArticleId><ArticleId IdType="pubmed">33193350</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang M., Niu H., Liu J., Ruilian M., Wang Y., Xiao Y., Xiao Z., Sun J., Dong Y., et al. Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis. Int. J. Biol. Macromol. 2019;126:179–186. doi: 10.1016/j.ijbiomac.2018.12.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2018.12.207</ArticleId><ArticleId IdType="pubmed">30586589</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H.L., Song J., Sun P., Song Q.Q., Sheng L.J., Chi M.M., Han J. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis. Virus Res. 2016;213:314–321. doi: 10.1016/j.virusres.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.01.003</ArticleId><ArticleId IdType="pubmed">26779987</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizer P., Klingel K., Sauter M., Westermann D., Ochmann C., Schönberger T., Schleicher R., Stellos K., Schmidt E.M., Borst O., et al. Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis. J. Mol. Cell. Cardiol. 2012;53:6–14. doi: 10.1016/j.yjmcc.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2012.03.004</ArticleId><ArticleId IdType="pubmed">22446162</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora K., Gwinn W.M., Bower M.A., Watson A., Okwumabua I., MacDonald H.R., Bukrinsky M.I., Constant S.L. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 2005;175:517–522. doi: 10.4049/jimmunol.175.1.517.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.1.517</ArticleId><ArticleId IdType="pmc">PMC2862457</ArticleId><ArticleId IdType="pubmed">15972687</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurchenko V., Constant S., Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology. 2006;117:301–309. doi: 10.1111/j.1365-2567.2005.02316.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02316.x</ArticleId><ArticleId IdType="pmc">PMC1782239</ArticleId><ArticleId IdType="pubmed">16476049</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S.M., Silva C., Wang J., Tong J.P., Yong V.W. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: Relevance to multiple sclerosis. J. Neuroinflamm. 2012;9:64. doi: 10.1186/1742-2094-9-64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-64</ArticleId><ArticleId IdType="pmc">PMC3423076</ArticleId><ArticleId IdType="pubmed">22480370</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwinn W.M., Damsker J.M., Falahati R., Okwumabua I., Kelly-Welch A., Keegan A.D., Vanpouille C., Lee J.J., Dent L.A., Leitenberg D., et al. Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention. J. Immunol. 2006;177:4870–4879. doi: 10.4049/jimmunol.177.7.4870.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.7.4870</ArticleId><ArticleId IdType="pmc">PMC2855298</ArticleId><ArticleId IdType="pubmed">16982929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J., Wang C., Shi Z., Zhao J., Jia Y., Zhao-Hui Z., Li X., Chen Z., Zhu P. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis. Rheumatologys. 2009;48:721–726. doi: 10.1093/rheumatology/kep099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kep099</ArticleId><ArticleId IdType="pubmed">19429906</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J., Wang Y., Sun Y., Huang J., Yan W., Wang J., Su D., Ni C., Li J., Rao Z., et al. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 2014;10:e1004422. doi: 10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushkarsky T., Zybarth G., Dubrovsky L., Yurchenko V., Tang H., Guo H., Toole B., Sherry B., Bukrinsky M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl. Acad. Sci. USA. 2001;98:6360–6365. doi: 10.1073/pnas.111583198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.111583198</ArticleId><ArticleId IdType="pmc">PMC33473</ArticleId><ArticleId IdType="pubmed">11353871</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell. 1995;80:213–223. doi: 10.1016/0092-8674(95)90404-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90404-2</ArticleId><ArticleId IdType="pubmed">7834741</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch C., Staffler G., Hüttinger R., Hilgert I., Prager E., Cerný J., Steinlein P., Majdic O., Horejsí V., Stockinger H. T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int. Immunol. 1999;11:777–786. doi: 10.1093/intimm/11.5.777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/11.5.777</ArticleId><ArticleId IdType="pubmed">10330283</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q.Q., Lu M.Z., Song J., Chi M.M., Sheng L.J., Yu J., Luo X.N., Zhang L., Yao H.L., Han J. Coxsackievirus B3 2A protease promotes encephalomyocarditis virus replication. Virus Res. 2015;208:22–29. doi: 10.1016/j.virusres.2015.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.05.020</ArticleId><ArticleId IdType="pubmed">26052084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z.G., Wang L., Cui H.Y., Peng J.L., Wang S.J., Geng J.J., Liu J.D., Feng F., Song F., Li L., et al. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells. Oncotarget. 2016;7:9429–9447. doi: 10.18632/oncotarget.6990.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6990</ArticleId><ArticleId IdType="pmc">PMC4891050</ArticleId><ArticleId IdType="pubmed">26882566</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen M.H., Tsao K.C., Huang Y.C., Huang C.G., Huang Y.L., Lin R., Chang M.L., Huang C.C., Yan D.C., Lin T.Y. Viral load in blood is correlated with disease severity of neonatal coxsackievirus B3 infection: Early diagnosis and predicting disease severity is possible in severe neonatal enterovirus infection. Clin. Infect. Dis. 2007;44:e78–e81. doi: 10.1086/515399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/515399</ArticleId><ArticleId IdType="pubmed">17443457</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao J., Li W., Bao J., Peng Q., Wen D., Wang J., Sun B. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues. Biochem. Biophys. Res. Commun. 2020;533:867–871. doi: 10.1016/j.bbrc.2020.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.09.042</ArticleId><ArticleId IdType="pmc">PMC7489930</ArticleId><ArticleId IdType="pubmed">33008593</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalay G., Sauter M., Hald J., Weinzierl A., Kandolf R., Klingel K. Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am. J. Pathol. 2006;169:2085–2093. doi: 10.2353/ajpath.2006.060350.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.060350</ArticleId><ArticleId IdType="pmc">PMC1762471</ArticleId><ArticleId IdType="pubmed">17148671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappritz K., Savvatis K., Miteva K., Kerim B., Dong F., Fechner H., Müller I., Brandt C., Lopez B., González A., et al. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis. FASEB J. 2018;32:6066–6078. doi: 10.1096/fj.201701408R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201701408R</ArticleId><ArticleId IdType="pubmed">29863913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesti-Costa R., Silva G.K., Proenca-Modena J.L., Carlos D., Silva M.L., Alves-Filho J.C., Arruda E., Liew F.Y., Silva J.S. The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J. Immunol. 2013;191:283–292. doi: 10.4049/jimmunol.1202806.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202806</ArticleId><ArticleId IdType="pubmed">23733876</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., Zhao E., Ilyas G., Lalazar G., Lin Y., Haseeb M., Tanaka K.E., Czaja M.J. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy. 2015;11:271–284. doi: 10.1080/15548627.2015.1009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1009787</ArticleId><ArticleId IdType="pmc">PMC4502775</ArticleId><ArticleId IdType="pubmed">25650776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H., Zhang Y., Luo Z., Li P., Liu L., Wang C., Wang H., Li H., Ma Y. Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014;306:L183–L195. doi: 10.1152/ajplung.00147.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00147.2013</ArticleId><ArticleId IdType="pubmed">24242010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainwright D.A., Sengupta S., Han Y., Ulasov I.V., Lesniak M.S. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS ONE. 2010;5:e15390. doi: 10.1371/journal.pone.0015390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015390</ArticleId><ArticleId IdType="pmc">PMC2963644</ArticleId><ArticleId IdType="pubmed">21060663</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyes L.R., Bego M.G., Soland M., St Jeor S. Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation. J. Gen. Virol. 2012;93:722–732. doi: 10.1099/vir.0.037309-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.037309-0</ArticleId><ArticleId IdType="pmc">PMC3542716</ArticleId><ArticleId IdType="pubmed">22238232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Ning J., Boggs E.A., Jang S., Wallace C., Telmer C., Bruchez M.P., Ahn J., Engelman A.N., Zhang P., et al. Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner. mBio. 2021;12:e03142-20. doi: 10.1128/mBio.03142-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03142-20</ArticleId><ArticleId IdType="pmc">PMC8092277</ArticleId><ArticleId IdType="pubmed">33758083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J.N., Kaushik D.K., Yong V.W. The role of EMMPRIN in T cell biology and immunological diseases. J. Leukoc. Biol. 2015;98:33–48. doi: 10.1189/jlb.3RU0215-045R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RU0215-045R</ArticleId><ArticleId IdType="pmc">PMC7166407</ArticleId><ArticleId IdType="pubmed">25977287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S., Liu H.L., Chapman N.M. Coxsackievirus B3: Primary structure of the 5′ non-coding and capsid protein-coding regions of the genome. Virus Res. 1985;3:263–270. doi: 10.1016/0168-1702(85)90050-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(85)90050-4</ArticleId><ArticleId IdType="pubmed">3000101</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau D.H., Yuan J., Zhang H., Cheung P., Lim T., Liu Z., Sall A., Yang D. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis Int. J. Program. Cell Death. 2007;12:513–524. doi: 10.1007/s10495-006-0013-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-006-0013-0</ArticleId><ArticleId IdType="pubmed">17195095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.Y. A common immunopathogenesis mechanism for infectious diseases: The protein-homeostasis-system hypothesis. Infect. Chemother. 2015;47:12–26. doi: 10.3947/ic.2015.47.1.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2015.47.1.12</ArticleId><ArticleId IdType="pmc">PMC4384454</ArticleId><ArticleId IdType="pubmed">25844259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.Y. Common immunopathogenesis of central nervous system diseases: The protein-homeostasis-system hypothesis. Cell Biosci. 2022;12:184. doi: 10.1186/s13578-022-00920-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00920-5</ArticleId><ArticleId IdType="pmc">PMC9668226</ArticleId><ArticleId IdType="pubmed">36384812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Li M., Xie Y., Yu Y., Liu G., Yu Y., Yang X., Zou Y., Ge J., Chen R. The frequency of invariant natural killer T cells correlates with the severity of myocarditis. Viral Immunol. 2014;27:88–95. doi: 10.1089/vim.2013.0078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2013.0078</ArticleId><ArticleId IdType="pubmed">24702483</ArticleId></ArticleIdList></Reference><Reference><Citation>De-Pu Z., Li-Sha G., Guang-Yi C., Xiaohong G., Chao X., Cheng Z., Wen-Wu Z., Jia L., Jia-Feng L., Maoping C., et al. The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4(+) T cell differentiation. Virulence. 2018;9:1364–1376. doi: 10.1080/21505594.2018.1482179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2018.1482179</ArticleId><ArticleId IdType="pmc">PMC6141146</ArticleId><ArticleId IdType="pubmed">30176160</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Stafford K.A., Sung Y.K. Update on coxsackievirus B3 myocarditis. Curr. Opin. Rheumatol. 2012;24:401–407. doi: 10.1097/BOR.0b013e328353372d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizer P., Geisler T., Bigalke B., Schneider M., Klingel K., Kandolf R., Stellos K., Schreieck J., Gawaz M., May A.E. EMMPRIN and its ligand cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy. Int. J. Cardiol. 2013;163:299–304. doi: 10.1016/j.ijcard.2011.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.06.049</ArticleId><ArticleId IdType="pubmed">21724278</ArticleId></ArticleIdList></Reference><Reference><Citation>Seizer P., Gawaz M., May A.E. Platelet-monocyte interactions—A dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr. Med. Chem. 2008;15:1976–1980. doi: 10.2174/092986708785132852.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986708785132852</ArticleId><ArticleId IdType="pubmed">18691053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiampanichayakul S., Peng-in P., Khunkaewla P., Stockinger H., Kasinrerk W. CD147 contains different bioactive epitopes involving the regulation of cell adhesion and lymphocyte activation. Immunobiology. 2006;211:167–178. doi: 10.1016/j.imbio.2005.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2005.08.007</ArticleId><ArticleId IdType="pubmed">16530084</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda K., Kosugi T., Sato W., Kojima H., Sato Y., Kamimura D., Kato N., Tsuboi N., Yuzawa Y., Matsuo S., et al. CD147/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6/STAT-3 pathway. Arthritis Rheumatol. 2015;67:2185–2195. doi: 10.1002/art.39155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39155</ArticleId><ArticleId IdType="pubmed">25891969</ArticleId></ArticleIdList></Reference><Reference><Citation>Okubo A., Uchida Y., Higashi Y., Sato T., Ogawa Y., Ryuge A., Kadomatsu K., Kanekura T. CD147 Is Essential for the Development of Psoriasis via the Induction of Th17 Cell Differentiation. Int. J. Mol. Sci. 2021;23:177. doi: 10.3390/ijms23010177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010177</ArticleId><ArticleId IdType="pmc">PMC8745261</ArticleId><ArticleId IdType="pubmed">35008603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukrinsky M.I. Cyclophilins: Unexpected messengers in intercellular communications. Trends Immunol. 2002;23:323–325. doi: 10.1016/S1471-4906(02)02237-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(02)02237-8</ArticleId><ArticleId IdType="pubmed">12103338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin R., Liu S., Wang M., Zhong W., Li G. Inhibition of CD147 Attenuates Stroke-Associated Pneumonia through Modulating Lung Immune Response in Mice. Front. Neurol. 2019;10:853. doi: 10.3389/fneur.2019.00853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00853</ArticleId><ArticleId IdType="pmc">PMC6692478</ArticleId><ArticleId IdType="pubmed">31447768</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo N., Ye S., Zhang K., Yu X., Cui H., Yang X., Lin P., Lv M., Miao J., Zhang Y., et al. A critical epitope in CD147 facilitates memory CD4(+) T-cell hyper-activation in rheumatoid arthritis. Cell. Mol. Immunol. 2019;16:568–579. doi: 10.1038/s41423-018-0012-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-018-0012-4</ArticleId><ArticleId IdType="pmc">PMC6804595</ArticleId><ArticleId IdType="pubmed">29563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue-Chun L., Gu X.H., Li-Sha G., Zhou D.P., Xing C., Guo X.L., Pan L.L., Song S.Y., Yu L.L., Chen G.Y., et al. Vagus nerve plays a pivotal role in CD4+ T cell differentiation during CVB3-induced murine acute myocarditis. Virulence. 2021;12:360–376. doi: 10.1080/21505594.2020.1869384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2020.1869384</ArticleId><ArticleId IdType="pmc">PMC7834089</ArticleId><ArticleId IdType="pubmed">33380272</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H., Guo X. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance. Virol. J. 2016;13:168. doi: 10.1186/s12985-016-0626-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0626-z</ArticleId><ArticleId IdType="pmc">PMC5057454</ArticleId><ArticleId IdType="pubmed">27724948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Yu M., Lin Q.W., Cao A.L., Yu X., Dong J.H., Wang J.P., Zhang J.H., Wang M., Guo H.P., et al. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. J. Immunol. 2010;185:4004–4010. doi: 10.4049/jimmunol.1001718.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1001718</ArticleId><ArticleId IdType="pubmed">20802148</ArticleId></ArticleIdList></Reference><Reference><Citation>Butera A., Quaranta M.T., Crippa L., Spinello I., Saulle E., Di Carlo N., Campanile D., Boirivant M., Labbaye C. CD147 Targeting by AC-73 Induces Autophagy and Reduces Intestinal Fibrosis Associated with TNBS Chronic Colitis. J. Crohn’s Colitis. 2022;16:1751–1761. doi: 10.1093/ecco-jcc/jjac084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjac084</ArticleId><ArticleId IdType="pmc">PMC9683082</ArticleId><ArticleId IdType="pubmed">35833587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushkarsky T., Yurchenko V., Laborico A., Bukrinsky M. CD147 stimulates HIV-1 infection in a signal-independent fashion. Biochem. Biophys. Res. Commun. 2007;363:495–499. doi: 10.1016/j.bbrc.2007.08.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.08.192</ArticleId><ArticleId IdType="pmc">PMC2080668</ArticleId><ArticleId IdType="pubmed">17888876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>